Skip to main content

Featured

BUSINESS GOVirtual Expo & Conference 2022

BUSINESS GOVirtual Expo & Conference (BUSINESS GOVirtual), the Hong Kong's first physical B2B "Tech x Business" event in the post-pandemic period, gathers leading IT companies and solutions providers under one roof to demonstrate their latest technologies. It is also the platform where showcases the key technological advancements for social and business engagement in the new digital era. The development of the Greater Bay Area is accorded the status of critical strategic planning in the Chinese government's blueprint, with great significance in China's initiative on innovation-driven development. Strategically held in Hong Kong, the international innovation and technology hub, BUSINESS GOVirtual serves as a communication platform for tech companies to exchange ideas, collaborate and foster partnerships. On top of the physical event, the brand new "GOVirtual OMNI," an online platform for the Expo and Conference, welcomes regional exhibitors and visito

COVID-19 vaccines closely monitored

The Department of Health (DH) has set up a reporting system online for healthcare professionals and the pharmaceutical industry to report adverse events following immunisations (AEFIs) of COVID-19 vaccines.   It has also written to healthcare professionals and relevant organisations, encouraging them to report suspected serious or unexpected AEFIs.   The law stipulates that it is necessary to put in place a mechanism for the monitoring of any adverse event occurring to the recipients associated with the administration of COVID-19 vaccines authorised for emergency use under the Government Vaccination Programme in Hong Kong.   The online reporting system and the move to urge to healthcare professionals to report SEFIs are in addition to the DH’s established system to receive and assess reports of AEFIs submitted by healthcare professionals and the pharmaceutical industry.   For active surveillance, the DH has also partnered with the University of Hong Kong Department of Pharmacology & Pharmacy to actively collect data of potential adverse events of authorised vaccines, in particular rare or serious adverse events of special interest from public and private healthcare facilities and conduct causality assessments.   To tie in with the aforementioned surveillance measures, the DH has established an expert committee for continuous monitoring of potential clinical events associated with COVID-19 vaccinations and to provide expert opinions and advice on the safety monitoring of authorised vaccines.   The Government is closely monitoring potential serious clinical events after immunisation of COVID-19 vaccines and committed to addressing public concerns. It is expected to release and update the data collected on the designated website from mid-March.
http://dlvr.it/RtbBKJ

Popular Posts